<DOC>
	<DOCNO>NCT03040609</DOCNO>
	<brief_summary>The main objective study develop validate visio-behavioral scale visual ability subject profound multiple intellectual disability . The secondary objective study : - validate structure scale . - evaluate reproducibility scale intra- inter-examiners , influence different profession examiner . - evaluate feasibility visio-behavioral scale . - evaluate sensitivity change . - study uniformity use scale depend type patient ( age , disability level , pathology ) . - study prevalence visual disorder profound multiple intellectual disability subject .</brief_summary>
	<brief_title>Development Visio-behavioral Scale Evaluate Visual Abilities Patients With Profound Multiple Intellectual Disabilities ( PLH-Vision )</brief_title>
	<detailed_description>This study include 3 phase : - Elaboration list behavioral item group multi-disciplinary expertise ( physician , nurse , caregiver , ophthalmology , orthoptist ) base clinical experience . - Development scale base sample obtain prospective multicenter research trial . - Validation sample obtain prospective transversal multicenter study . This study perform 5 center France . The enrollment patient plan 24 month target 310 patient . The duration follow-up study patient vary accord group patient , il 1 day group 1 , 2 week group 2 , 6 month group 3 .</detailed_description>
	<mesh_term>Intellectual Disability</mesh_term>
	<criteria>Causal brain injury occur age 3 year . Severe deep mental retardation define DSM IV . Motor impairment : para / tetraparesis , hemiparesis , ataxia , extrapyramidal motor disorder . Score Gross Motor Function Classification System [ Palisano 1997 ] III , IV V. Score Functional Independence Measure &lt; 55 ( subject age â‰¥3 year , visiobehavioral scale adapt child young 3 year ) . Beneficiary social protection . Written consent sign guardian legal representative , parent case minor subject . Acute intercurrent pathology preclude examination . Patient hypersensitivity tropicamide , atropine benzalkonium chloride . Angle closure glaucoma suspect patient . Patient coronary insufficiency . Patient severe hypertension . Patient undergoing antiepileptic drug . Short life expectancy .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Profound Multiple Intellectual Disabilities</keyword>
	<keyword>Visual-Behavioral Scale</keyword>
</DOC>